Somatostatin and its receptors in the development of the endocrine pancreas

Pancreas

Volumn 33, Issue 1, 2006, Pages 1-12

  Ballian, Nikiforos ^a   Brunicardi, F Charles ^a   Wang, Xiao Ping ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Pancreas; Somatostatin; Somatostatin receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; HORMONE; ION; NEUROTRANSMITTER; PEPTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; TRANSCRIPTION FACTOR;

AGE; DIABETES MELLITUS; HORMONAL REGULATION; HUMAN; MAMMAL; NONHUMAN; ORGANOGENESIS; PANCREAS CANCER; PANCREAS ISLET; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; ORGANOGENESIS; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; SOMATOSTATIN; TRANSCRIPTION FACTORS;

EID: 33745727212     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000226894.16817.e8     Document Type: Review

References (172)

1. Tirone TA, Wang XP, Templeton NS, et al. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase directed gene therapy. World J Surg. 2004;28:826-833.
2. Koizumi M, Doi R, Oyoda E, et al. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery. 2003;134:260-266.
3. Wang XP, Yang J, Norman MA, et al. SSTR5 ablation in islet results in alterations in glucose homeostasis in mice. FEBS Lett. 2005;579:3107-3114.
4. Benali N, Cordelier P, Calise D, et al. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtypes 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A. 2000;97:9180-9185.
5. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20:157-198.
6. Patel YC, Liu J, Galanopoulou A, et al. Production, action, and degradation of somatostatin. In: Jefferson LS, Cherrington AD, Goodman, HM, eds. Handbook of Physiology: Section 7: The Endocrine System. Oxford: Oxford University Press; 2001:267-302.
7. Stefan Y, Grasso S, Perrelet A, et al. A quantitative immunofluorescent study of the endocrine cell populations in the developing human pancreas. Diabetes. 1983;32:293-301.
8. Grube D, Bohn R. The microanatomy of human islets of Langerhans, with special reference to somatostatin (D-) cells. Arch Histol Jpn. 1983;46:327-353.
9. Ahlgren U, Edlund H. Homeodomain proteins in pancreas development. In: Habener JF, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:197-212.
10. Zhou X, Gruss P. Pax4 and Pax6 in islet differentiation. In: Habener F, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:239-254.
11. Sander M, Neubuser A, Kalamaras J, et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 1997;24:36-44.
12. Maldonado TS, Crisera CA, Kadison AS, et al. Role of mesenchymal- epithelial interactions in pancreas development. In: Habener JF, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:177-195.
13. Wessells N, Cohen J. Early pancreas organogenesis: morphogenesis, tissue interaction and mass effects. Dev Biol. 1967;15:237-270.
14. Rose MI, Crisera CA, Colen KL, et al. Epithelio-mesenchymal interactions in the developing mouse pancreas: morphogenesis of the adult architecture. J Pediatr Surg. 1999;34:774-779. [discussion 780].
15. Cirulli V, Crisa L, Beattie GM, et al. KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol. 1998;140:1519-1534.
16. Esni F, Taljedal I, Perl A, et al. Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets. J Cell Biol. 1999;144:325-337.
17. Cirulli V, Beattie GM, Klier G, et al. Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. J Cell Biol. 2000;150:1445-1460.
18. Kantengwa S, Baetens D, Sadoul K, et al. Identification and characterization of alpha 3 beta 1 integrin on primary and transformed rat islet cells. Exp Cell Res. 1997;237:394-402.
19. Bosco D, Meda P, Halban PA, et al. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes. 2000;49:233-243.
20. Meda P, Bosco D. Communication of islet cells: molecules and functions. In: Habener JF, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:143-163.
21. Sander M, German M. The beta cell transcription factors and development of the pancreas. J Mol Med. 1997;75:327-340.
22. German M, Ashcroft S, Docherty K, et al. The insulin gene promoter. A simplified nomenclature. Diabetes. 1995;44:1002-1004.
23. Naya FJ, Huang HP, Qiu Y, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/Neuro D-deficient mice. Genes Dev. 1997;11:2323-2334.
24. Miyata T, Maeda T, Lee J. NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev. 1999;13:1647-1652.
25. Kojima H, Fujimiya M, Matsumura K, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med. 2003;9:596-603.
26. Krapp A, Knofler M, Frutiger S, et al. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein. EMBO J. 1996;15:4317-4329.
27. Krapp A, Knofler M, Ledermann B, et al. The bHLH protein PTF-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 1998;12:3752-3763.
28. Anderson DJ. Lineages and transcription factors in the specification of vertebrate primary sensory neurons. Curr Opin Neurobiol. 1999;9:517-524.
29. Fode C, Gradwohl G, Morin X, et al. The bHLH protein Neurogenin 2 is a determination factor for epibranchial placode-derived sensory neurons. Neuron. 1998;20:483-484.
30. Fode C, Ma Q, Casarosa S, et al. A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons. Genes Dev. 2000;14:67-80.
31. Ma Q, Fode C, Guillemot F, et al. Neurogenin 1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia. Genes Dev. 1999;13:1717-1728.
32. Jensen J, Flores LE, Heller RS, et al. bHLH factors and Notch in pancreatic development. In: Habener JF, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:214-227.
33. Gradwohl G, Dierich A, LeMeur M, et al. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A. 2000;97:1607-1611.
34. Edlund H. Transcribing pancreas. Diabetes. 1998;47:1817-1823.
35. Ahlgren U, Pfaff S, Jessell T, et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature. 1997;385(6613):257-260.
36. Leonard J, Peers B, Hohnson T, et al. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol. 1993;7:1257-1283.
37. Ohlsson H, Karlsson K, Edlund T. IPF-1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 1993;12:4251-4259.
38. Ashizawa S, Brunicardi FC, Wang XP. PDX-1 and the pancreas. Pancreas. 2004;28:109-120.
39. Guz Y, Montmity MR, Stein R, et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development. 1995;121:11-18.
40. Watada H, Kajimoto Y, Miyagawa J, et al. PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes. 1996;45:1826-1831.
41. Bretherton-Watt D, Gore N, Boam DS. Insulin upstream factor 1 and a novel ubiquitous factor bind to the human islet amyloid polypeptide/amylin gene promoter. Biochem J. 1996;313:495-502.
42. Carty MD, Lillquist JS, Peshavaria M, et al. Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells. J Biol Chem. 1997;272:11986-11993.
43. Serup P, Jensen J, Andersen FG, et al. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc Natl Acad Sci U S A. 1996;93:9015-9020.
44. Watada H, Kajimoto Y, Kaneto H, et al. Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem Biophys Res Commun. 1996;229:746-751.
45. Peshavaria M, Gamer L, Henderson E, et al. XIHBox8, an endoderm-specific Xenopus homeodomain protein, is closely related to a mammalian insulin gene transcription factor. Mol Endocrinol. 1994;8:806-816.
46. Ahlgren U, Jonsson J, Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development. 1996;122:1409-1416.
47. Jonsson J, Carlsson L, Edlund T, et al. Insulin promoter factor 1 is required for pancreas development in mice. Nature. 1994;371:606-609.
48. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development. 1996;122:983-995.
49. Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997;15:106-110.
50. Wang XP, Li ZJ, Magnusson J, et al. Tissue MicroArray analyses of pancreatic duodenal homeobox-1 (PDX-1) in human cancers. World J Surg. 2005;29:334-338.
51. Sosa-Pineda B, Chowdury K, Torres M, et al. The Pax4 gene is essential for differentiation of insulin-producing cells in the mammalian pancreas. Nature. 1997;386:399-402.
52. St-Onge L, Sosa-Pineda B, Chowdhury K, et al. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature. 1997;387(6631):406-409.
53. Ritz-Laser B, Estreicher A, Gauthier BR, et al. The pancreatic beta-cell specific transcription factor Pax-4 inhibits glucagon gene expression through Pax-6. Diabetologia. 2002;45:97-107.
54. Harrison K, Thaler J, Pfaff S, et al. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat Genet. 1999;23:71-75.
55. Li H, Arber S, Jessell TM, et al. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat Genet. 1999;23:67-70.
56. Sander M, Sussel L, Conners J, et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development. 2000;127:5533-5540.
57. Stoffel M. The role of the hepatocyte nuclear factor network in glucose homeostasis. In: Habener JF, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:255-274.
58. Jacquemin P, Durviaux S, Jensen J, et al. Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol. 2000;20:4445-4454.
59. Lee JC, Smith SB, Watada H, et al. Regulation of the pancreatic proendocrine gene neurogenin3. Diabetes. 2001;50:928-936.
60. Zaret K. Developmental competence of the gut endoderm: genetic potentiation by GATA and HNF3/fork head proteins. Dev Biol. 1999;209:1-10.
61. Ketola I, Otonkoski T, Pulkinnen MA, et al. Transcription factor GATA-6 is expressed in the endocrine and GATA-4 in the exocrine pancreas. Mol Cell Endocrinol. 2004;226:51-57.
62. Scharfmann R, Czernichow P. Soluble factors important for pancreas development. In: Habener JF, Hussain M, eds. Molecular Basis of Pancreas Development and Function. Norwell: Kluwer Academic Publishers; 2001:165-175.
63. Nguyen H, Danilenko D, Bucay N, et al. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene. 1996;12:2109-2119.
64. Celli G, LaRochelle W, Mackem S, et al. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J. 1998;17:1642-1655.
65. Sanvito F, Herrera PL, Huarte J, et al. TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development. 1994;120:3451-3462.
66. Miettinen PJ, Huotari M, Koivisto T, et al. Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development. 2000;127:2617-2627.
67. Miettinen PJ. Epidermal growth factor receptor in mice and men - any applications to clinical practice? Ann Med. 1997;29:531-534.
68. Jhappan C, Stahle C, Harkins RN, et al. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 1990;61:1137-1146.
69. Sandgren LP, Luetteke NC, Palmiter RD, et al. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia and carcinoma of the breast. Cell. 1990;61:121-135.
70. Mashima H, Yamada S, Tajima T, et al. Genes expressed during the differentiation of pancreatic AR42J cells into insulin-secreting cells. Diabetes. 1999;48:304-309.
71. Yamaoka T, Idehara C, Yano M, et al. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest. 1998;102:294-301.
72. Shiozaki S, Tajima T, Zhang YG, et al. Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mice expressing the truncated type II activin receptor. Biochim Biophys Acta. 1999;1450:1-11.
73. Yasuda H, Inoue K, Takeuchi T, et al. Existence of Activin-A in A- and D-cells of pancreatic islet. Endocrinology. 1993;133:624-630.
74. Miralles F, Czernichow P, Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development. 1998;125:1017-1024.
75. Miralles F, Battelino T, Czernichow P, et al. TGF-b plays a key role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2. J Cell Biol. 1998;143:827-836.
76. Harmon EB, Apelqvist AA, Smart NG, et al. GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development. 2004;131:6163-6174.
77. Bottinger EP, Jakubczak JL, Roberts ISD, et al. Expression of a dominant-negative mutant TGF-b type II receptor in transgenic mice reveals essential roles for TGF-b in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 1997;16:2621-2633.
78. Sanvito F, Nichols A, Herrera PL, et al. TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes. Biochem Biophys Res Commun. 1995;217:1279-1286.
79. Miralles F, Serup P, Cluzeaud F, et al. Characterization of beta cells developed in vitro from rat embryonic pancreatic epithelium. Dev Dyn. 1999;214:116-126.
80. Apelqvist A, Ahlgren U, Edlund H. Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr Biol. 1997;7:801-804.
81. Deutsch G, Jung J, Zheng M, et al. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development. 2001;128:871-881.
82. Krulich L, Dhariwal AP, McCann SM. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 1968;83:783-790.
83. Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973;179:77-79.
84. Funckes CL, Deschenes CD, Magazin R, et al. Cloning and characterization of a mRNA-encoding rat preprosomatostatin. J Biol Chem. 1983;258:8781-8787.
85. Montminy M, Goodman R, Horovitch S, et al. Primary structure of the gene encoding rat preprosomatostatin. Proc Natl Acad Sci U S A. 1984;81:3337-3340.
86. Noe BD, Andrews PC, Dixon JE, et al. Localization and characterization of neuropeptide Y-like peptides in the brain and islet organ of the anglerfish (Lophius americanus). Cell Tissue Res. 1986;257:303-311.
87. Day R, Benjannet S, Matsuuchi L, et al. Maintained PC1 and PC2 expression in the AtT-20 variant cell line 6T3 lacking regulated secretion and POMC: restored POMC expression and regulated secretion after cAMP treatment. DNA Cell Biol. 1995;14:175-188.
88. Patel Y, Wheatley T, Ning C. Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat. Endocrinology. 1981;109:1943-1949.
89. Ferone D, Kwekkeboom DJ, Koetsveld PM, et al. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro. J Clin Endocrinol Metab. 2000;85:1719-1726.
90. Ferone D, Colao A, Annunziato L, et al. Somatostatin receptors in the thymus. Ann Med. 1999;31:28-33.
91. Vallejo M, Miller CP, Habener JF. Somatostatin gene transcription regulated by a bipartite pancreatic islet D-cell-specific enhancer coupled synergetically to a cAMP response element. J Biol Chem. 1992;267:12868-12875.
92. Benuck M, Marks N. Differences in the degradation of hypothalamic releasing factors by rat and human serum. Life Sci. 1976;19:1271-1276.
93. Marks N, Stern F, Benuck M. Correlation between biological potency and biodegradation of a somatostatin analogue. Nature. 1976;261:511-512.
94. Polonsky KS, Jaspan JB, Berelowitz M, et al. Hepatic and renal metabolism of somatostatin-like immunoreactivity Simultaneous assessment in the dog. J Clin Invest. 1981;68:1149-1157.
95. Lamberts S, Lely A-JVD. Drug therapy: octreotide. N Engl J Med. 1996;334:246-254.
96. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci U S A. 1998;95:12544-12549.
97. Wang XP, Norman M, Brunicardi FC. Somatostatin receptors and autoimmune-mediated diabetes. Diabetes Metab Res Rev. 2005;21:15-30.
98. Patel Y, Amherdt M, Orci L. Quantitative electron microscopic autoradiography of insulin, glucagon, and somatostatin binding sites on islets. Science. 1982;217:1155-1156.
99. Samols E, Stagner JI, Ewart RBL, et al. The order of microvascular cellular perfusion is B-A-D in the perfused rat pancreas. J Clin Invest. 1988;83:350-354.
100. Samols E, Stagner J. Islet somatostatin - microvascular, paracrine and pulsatile regulation. Metabolism. 1990;39:55-60.
101. Trimble ER, Gerber PG, Renold AE. Effects of synthetic human pancreatic polypeptide, synthetic bovine pancreatic polypeptide, and the C-terminal hexapeptide on pancreatic somatostatin and glucagon secretion in the rat. Diabetes. 1982;31:178-181.
102. Gerich JE. Role of somatostatin and its analogues in the pathogenesis and treatment of diabetes mellitus. Metabolism. 1990;39:52-54.
103. Gutniak M, Grill V, Wiechel KL, et al. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization. Diabetes. 1987;36:802-807.
104. Kleinman R, Gingerich R, Ohning G, et al. The influence of somatostatin on glucagon and pancreatic polypopeptide secretion in the isolated perfused human pancreas. Int J Pancreatol. 1995;18:51-57.
105. Nelson-Piercy C, Hammond PJ, Gwilliam ME, et al. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J Clin Endocrinol Metab. 1994;78:329-336.
106. Kleinman R, Gingerich R, Ohning G, et al. Intraislet regulation of pancreatic polypeptide secretion in the isolated perfused rat pancreas. Pancreas. 1997;15:384-391.
107. Kleinman RM, Fagan SP, Ray MK, et al. Differential inhibition of insulin and islet amyloid polypeptide secretion by intraislet somatostatin in the isolated perfused human pancreas. Pancreas. 1999;19:346-352.
108. Brunicardi FC, Kleinman R, Moldovan S, et al. Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas. 2001;23:302-308.
109. Brunicardi FC, Wen D, Bradley JC, et al. The effect of intraislet somatostatin immunoneutralization on insulin secretion in the isolated perfused rat pancreas. Int J Surg Invest. 2000;1:381-388.
110. Stagner JI, Samols E, Koerker DJ, et al. Perfusion with anti-insulin gamma globulin indicates a B to A to D cellular perfusion sequence in the pancreas of the rhesus monkey, Macaca mulatta. Pancreas. 1992;7:26-29.
111. Stagner JI, Samols E, Marks V. Antegrade and retrograde infusion of glucagon antibodies suggests that the A cells are vascularly perfused before D cells within the rat islet. Diabetologia. 1989;32:203-206.
112. Mandarino L, Stenner D, Blanchard W, et al. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 1981;291:76-77.
113. Philippe J. Somatostatin inhibits insulin-gene expression through a posttranscriptional mechanism in a hamster islet cell line. Diabetes. 1993;42:244-249.
114. Redmon JB, Towle HC, Robertson RP. Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. Diabetes. 1994;43:546-551.
115. Zhang HJ, Redmon JB, Andresen JM, et al. Somatostatin and epinephrine decrease insulin messenger ribonucleic acid in HIT cells through a pertussis toxin-sensitive mechanism. Endocrinology. 1991;129:2409-2414.
116. Frankel BJ, Heldt AM, Grodsky GM. Effects of K+ and arginine on insulin, glucagon, and somatostatin release from the in vitro perfused rat pancreas. Endocrinology. 1982;110:428-431.
117. Montminy MR, Low MJ, Tapia-Arancibia L, et al. Cyclic AMP regulates somatostatin mRNA accumulation in primary diencephalic cultures and in transfected fibroblast cells. J Neurosci. 1986;6:1171-1176.
118. Meyer TE, Habener JF. Cyclic adenosine 3,5-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr Rev. 1993;14:269-290.
119. Montminy M, Brindle P, Arias J, Ferreri K, Armstrong R. Regulation of somatostatin gene transcription by cAMP. In: Ciba Foundation Symposium 190. West Sussex, UK; 1995:7-20.
120. Dash PK, Karl KA, Colicos MA, et al. cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1991;88:5061-5065.
121. Sheng M, Thompson MA, Greenberg ME. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science. 1991;252:1427-1430.
122. Peers P, Sharma S, Johnson T, et al. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol Cell Biol. 1995;15:7091-7097.
123. Itkin-Ansari P, Demeterco C, et al. PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. Mol Endocrinol. 2000;14:814-822.
124. Scarborough DE. Somatostatin regulation by cytokines. Metabolism. 1990;39:108-111.
125. Liu JL, Papachristou DN, Patel YC. Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway. Biochem J. 1994;301(Pt 3):863-869.
126. Papachristou DN, Liu JL, Patel YC. Glucocorticoids regulate somatostatin peptide and steady state messenger ribonucleic acid levels in normal rat tissues and in a somatostatin-producing islet tumor cell line (1027B2). Endocrinology. 1994;134:2259-2266.
127. Liu JL, Patel YC. Glucocorticoids inhibit somatostatin gene expression through accelerated degradation of somatostatin messenger ribonucleic acid in human thyroid medullary carcinoma (TT) cells. Endocrinology. 1995;136:2389-2396.
128. Aguila M. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc Natl Acad Sci U S A. 1994;91:782-786.
129. Patel YC, Liu JL, Warszynska A, et al. Differential stimulation of somatostatin but not neuropeptide Y gene expression by quinolinic acid in cultured cortical neurons. J Neurochem. 1995;65:998-1006.
130. Vallejo M, Miller CP, Beckman W, et al. Repression of somatostatin gene transcription mediated by two promoter silencer elements. Mol Cell Endocrinol. 1995;113:61-72.
131. Lahlou M, Guillermet J, Hortala M, et al. Molecular signaling of somatostatin receptors. Ann N Y Acad Sci. 2004;1014:121-131.
132. Fukusumi S, Kitada C, Takekawa S, et al. Identification and characterization of a novel human corticostatin like peptide. Biochem Biophys Res Commun. 1997;232:157-163.
133. Lecea LD, Criado J, Prospero-Garcia O, et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature. 1996;381:242-245.
134. Ramirez JL, Mouchantaf R, Kumar U, et al. Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. Mol Endocrinol. 2002;16:1951-1963.
135. Lamberts SWJ, Hofland LJ. Somatostatin analogs in the diagnosis and treatment of cancer. Trends Endocrinol Metab. 2002;13:451-457.
136. Bell GI, Yasuda K, Kong H, et al. Molecular biology of somatostatin receptors. Ciba Found Symp. 1995;190:65-88.
137. Bruns C, Weckbecker G, Raulf F, et al. Characterization of somatostatin receptor subtypes. Ciba Found Symp. 1995;190:89-110.
138. Rajeswaran W, Hocart S, Murphy W, et al. Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist. J Med Chem. 2001;44:1305-1311.
139. Yamada Y, Reisine T, Law S, et al. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylate cyclase. Mol Endocrinol. 1993;6:2136-2142.
140. Yasuda K, Rens-Domiano S, Breder CD, et al. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenycyclase. J Biol Chem. 1992;267:20422-20428.
141. Breder CD, Yamada Y, Yasuda K, et al. Differential expression of somatostatin receptor subtypes in brain. J Neurosci. 1992;12:3920-3934.
142. Bruno J, Xu Y, Song J, et al. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology. 1993;133:2561-2567.
143. Hoyer D, Lubbert H, Bruns C. Molecular pharmacology of somatostatin receptor subtypes. Arch Pharmacol. 1994;350:441-453.
144. Kumar U, Sasi R, Suresh S, et al. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis. Diabetes. 1999;48:77-85.
145. Schally AV. Oncological applications of somatostatin analogues. Cancer Res. 1988;48:6977-6985.
146. Cordelier P, Esteve JP, Bousquet C, et al. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci U S A. 1997;94:9343-9348.
147. Buscail L, Esteve J-P, Saint-Laurent N, et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci U S A. 1995;92:1580-1584.
148. Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol. 1996;10:1688-1696.
149. Sharma K, Patel YC, Srikant CB. C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Mol Endocrinol. 1999;13:82-90.
150. Rosskopf D, Schurks M, Manthey I, et al. Signal transduction of somatostatin in human B lymphoblasts. Am J Physiol Cell Physiol. 2003;284:C179-C190.
151. Cattaneo MG, Taylor JE, Culler MD, et al. Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells. FEBS Lett. 2000;481:271-276.
152. Pages P, Benali N, Saint-Laurent N, et al. Sst2 somatostatin receptor mediates cell cycle arrest and induction of p27Kip1. J Biol Chem. 1999;274:15186-15193.
153. Buscail L, Delesque N, Esteve J, et al. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci U S A. 1994;91:2315-2319.
154. Komatsuzaki K, Murayama Y, Giambarella U, et al. A novel system that reports the G-proteins linked to a given receptor: a study of type 3 somatostatin receptor. FEBS Lett. 1997;406:165-170.
155. Reisine T, Woulfe D, Raynor K, et al. Interaction of somatostatin receptors with G proteins and cellular effector systems. Ciba Found Symp. 1995;190:160-170.
156. Kleuss C, Scherubl H, Hescheler J, et al. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science. 1993;259:832-834.
157. Tallent M, Reisine T. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells. Mol Pharmacol. 1992;41:452-455.
158. Bell GI, Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci. 1993;16:34-38.
159. Tietz PS, Alpini G, Pham LD, et al. Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. Am J Physiol Endocrinol Metab. 1995;269:G110-G118.
160. Schweitzer R, Madamba S, Siggins G. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature. 1990;346:464-466.
161. Lopez F, Esteve JP, Buscail L, et al. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem. 1997;272:24448-24454.
162. Hukovic N, Panetta R, Kumar U, et al. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology. 1996;137:4046-4049.
163. Rocheville M, Lange DC, Kumar U, et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 2000;288:154-157.
164. Pfeiffer M, Koch T, Schroder H, et al. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization and desensitization. J Biol Chem. 2002;277:19762-19772.
165. Pfeiffer M, Koch T, Schroder H, et al. Home- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem. 2001;276:14027-14036.
166. Wang XP, Norman MA, Yang J, Magnusson J, DeMayo FJ, Brunicardi FC. SSTR1 regulates insulin secretion in mice. Mol Cell Endocrinol. 2006;247(1-2):82-90.
167. Wang XP, Norman MA, Yang J, Liu SH, Magnusson J, DeMayo FJ, Brunicardi FC. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice. J Surg Res. 2005;129(1):64-72.
168. Wang XP, Norman MA, Yang J, et al. Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice. Surgery. 2004;136:585-592.
169. Buscail L, Saint-Laurent N, Chastre E, et al. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res. 1996;56:1823-1827.
170. Tang C, Biemond I, Verspaget HW, et al. Expression of somatostatin receptors in human pancreatic tumor. Pancreas. 1998;17:80-84.
171. Delesque N, Buscail L, Esteve JP, et al. Sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res. 1997;57:956-962.
172. Rochaix P, Delesque N, Esteve JP, et al. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther. 1999;10(6):857-859.